Mammography Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Mammography Equipment Pipeline Market Report Overview

Mammography equipment is a type of medical imaging equipment that uses X-rays to capture mammograms of the internal structures of the breasts. They play a key role in the early diagnosis of breast cancer.

The Mammography Equipment pipeline market research report provides comprehensive information about the Mammography equipment pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Segments ·       Breast Tomosynthesis

·       Full Field Digital Mammography Equipment

·       2D Digital Mammography Equipment

Key Territories ·       The US

·       Europe

·       Canada

·       China

·       Costa Rica

·       El Salvador

·       Mexico

·       South Africa

Key Regulatory Paths ·       510(k)

·       CE

·       MDL

·       NMPA

·       PMA

Leading Companies ·       Agfa HealthCare NV

·       Annalise-AI Pty Ltd

·       Canon USA Inc

·       CapeRay Medical Pty Ltd

·       Cooper Union for the Advancement of Science and Art

·       Fischer Imaging Corp

·       Florida International University

·       FMI Medical Systems Inc

·       GE Global Research

·       GE HealthCare Technologies Inc

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Mammography Equipment Pipeline Market by Segments

The key segments in the Mammography equipment pipeline market are Breast Tomosynthesis, Full Field Digital Mammography Equipment, and 2D Digital Mammography Equipment. As of October 2023, Breast Tomosynthesis and Full Field Digital Mammography Equipment have equal numbers of products.

Mammography Equipment Pipeline Market Analysis by Segments, 2023 (%)

Mammography Equipment Pipeline Market Analysis by Segments, 2023 (%)

Buy Full Report for More Segment Insights into the Mammography Equipment Pipeline Market

Download A Free Report Sample

Mammography Equipment Pipeline Market Segmentation by Territories

Some of the key territories in the Mammography equipment market are the US, Europe, Canada, China, Costa Rica, El Salvador, Mexico, and South Africa. As of October 2023, the US has the highest number of pipeline products.

Mammography Equipment Pipeline Market Analysis by Territories, 2023 (%)

Mammography Equipment Pipeline Market Analysis by Territories, 2023 (%)

Buy Full Report for More Territory Insights into the Mammography Equipment Pipeline Market

Download A Free Report Sample

Mammography Equipment Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the Mammography equipment pipeline market are 510(k), CE, MDL, NMPA, and PMA. As of October 2023, 510(k) is the most followed pathway for pipeline products in the market.

Mammography Equipment Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Mammography Equipment Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy Full Report for More Regulatory Path Insights into the Mammography Equipment Pipeline Market

Download A Free Report Sample

Mammography Equipment Pipeline Market – Competitive Landscape

Some of the key companies in the Mammography equipment pipeline market are Agfa HealthCare NV, Annalise-AI Pty Ltd, Canon USA Inc, CapeRay Medical Pty Ltd, Cooper Union for the Advancement of Science and Art, Fischer Imaging Corp, Florida International University, FMI Medical Systems Inc, GE Global Research, and GE HealthCare Technologies Inc.

Agfa HealthCare NV: It is a healthcare information technology company that provides eHealth and digital imaging solutions. The company provides software for digital radiography, diagnostic imaging, and healthcare IT solutions for hospitals and care centers. Agfa HealthCare service offerings include clinical workflow optimization patient engagement consulting and training and security, support, and specialty services. Agfa HealthCare is headquartered in Mortsel, Belgium.

Annalise-AI Pty Ltd: They are a developer of AI products that improve the delivery of medical imaging services. Annalise is headquartered in Sydney, New South Wales, Australia.

Mammography Equipment Pipeline Market Analysis by Companies, 2023

Mammography Equipment Pipeline Market Analysis by Companies, 2023

Buy Full Report for More Company Insights into the Mammography Equipment Pipeline Market

Download A Free Report Sample

Segments Covered in the Report

Mammography Equipment Pipeline Market Segments Outlook

  • Breast Tomosynthesis
  • Full Field Digital Mammography Equipment
  • 2D Digital Mammography Equipment

Mammography Equipment Pipeline Market Territories Outlook

  • The US
  • Europe
  • Canada
  • China
  • Costa Rica
  • El Salvador
  • Mexico
  • South Africa

Mammography Equipment Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • MDL
  • NMPA
  • PMA

Scope

This report provides:

  • Extensive coverage of the Mammography Equipment under development.
  • Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities.
  • Reviews of major players involved in the pipeline product development and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Provides key clinical trial data related to ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Mammography Equipment under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Agfa HealthCare NV
Annalise-AI Pty Ltd
Canon USA Inc
CapeRay Medical Pty Ltd
Cooper Union for the Advancement of Science and Art
Fischer Imaging Corp
Florida International University
FMI Medical Systems Inc
GE Global Research
GE HealthCare Technologies Inc
Health Discovery Corp
Imagine Scientific Inc
Imaging Diagnostic Systems, Inc.
Lawrence Livermore National Laboratory
Micrima Ltd.
Microwave Vision SA
Mobile Electronic Diagnostics (MobED)
NovaScan Inc
PETsys Electronics SA
Philips Healthcare
Real Time Tomography LLC
The University of Manchester
TomoWave Laboratories Inc
University at Buffalo
University College London
University of Calgary
University of Canterbury
University of Chicago
University of Michigan
University of South Florida
Weinberg Medical Physics LLC
XLV Diagnostics, Inc.

Table of Contents

1 Table of Contents 3

1.1 List of Tables 6

1.2 List of Figures 9

2 Introduction 10

2.1 Mammography Equipment Overview 10

3 Products under Development 11

3.1 Mammography Equipment – Pipeline Products by Stage of Development 11

3.2 Mammography Equipment – Pipeline Products by Segment 12

3.3 Mammography Equipment – Pipeline Products by Territory 13

3.4 Mammography Equipment – Pipeline Products by Regulatory Path 14

3.5 Mammography Equipment – Pipeline Products by Estimated Approval Date 15

3.6 Mammography Equipment – Ongoing Clinical Trials 16

4 Mammography Equipment – Pipeline Products under Development by Companies 17

4.1 Mammography Equipment Companies – Pipeline Products by Stage of Development 17

4.2 Mammography Equipment – Pipeline Products by Stage of Development 19

5 Mammography Equipment Companies and Product Overview 21

5.1 Agfa HealthCare NV Company Overview 21

5.1.1 Agfa HealthCare NV Pipeline Products & Ongoing Clinical Trials Overview 21

5.2 Annalise-AI Pty Ltd Company Overview 22

5.2.1 Annalise-AI Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 22

5.3 Canon USA Inc Company Overview 23

5.3.1 Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview 23

5.4 CapeRay Medical Pty Ltd Company Overview 24

5.4.1 CapeRay Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 24

5.5 Cooper Union for the Advancement of Science and Art Company Overview 27

5.5.1 Cooper Union for the Advancement of Science and Art Pipeline Products & Ongoing Clinical Trials Overview 27

5.6 Fischer Imaging Corp Company Overview 28

5.6.1 Fischer Imaging Corp Pipeline Products & Ongoing Clinical Trials Overview 28

5.7 Florida International University Company Overview 31

5.7.1 Florida International University Pipeline Products & Ongoing Clinical Trials Overview 31

5.8 FMI Medical Systems Inc Company Overview 32

5.8.1 FMI Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.9 GE Global Research Company Overview 33

5.9.1 GE Global Research Pipeline Products & Ongoing Clinical Trials Overview 33

5.10 GE HealthCare Technologies Inc Company Overview 34

5.10.1 GE HealthCare Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 34

5.11 Health Discovery Corp Company Overview 35

5.11.1 Health Discovery Corp Pipeline Products & Ongoing Clinical Trials Overview 35

5.12 Imagine Scientific Inc Company Overview 36

5.12.1 Imagine Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.13 Imaging Diagnostic Systems, Inc. Company Overview 37

5.13.1 Imaging Diagnostic Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37

5.14 Lawrence Livermore National Laboratory Company Overview 39

5.14.1 Lawrence Livermore National Laboratory Pipeline Products & Ongoing Clinical Trials Overview 39

5.15 Micrima Ltd. Company Overview 40

5.15.1 Micrima Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40

5.16 Microwave Vision SA Company Overview 41

5.16.1 Microwave Vision SA Pipeline Products & Ongoing Clinical Trials Overview 41

5.17 Mobile Electronic Diagnostics (MobED) Company Overview 44

5.17.1 Mobile Electronic Diagnostics (MobED) Pipeline Products & Ongoing Clinical Trials Overview 44

5.18 NovaScan Inc Company Overview 45

5.18.1 NovaScan Inc Pipeline Products & Ongoing Clinical Trials Overview 45

5.19 PETsys Electronics SA Company Overview 46

5.19.1 PETsys Electronics SA Pipeline Products & Ongoing Clinical Trials Overview 46

5.20 Philips Healthcare Company Overview 47

5.20.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 47

5.21 Real Time Tomography LLC Company Overview 49

5.21.1 Real Time Tomography LLC Pipeline Products & Ongoing Clinical Trials Overview 49

5.22 The University of Manchester Company Overview 50

5.22.1 The University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 50

5.23 TomoWave Laboratories Inc Company Overview 51

5.23.1 TomoWave Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 51

5.24 University at Buffalo Company Overview 52

5.24.1 University at Buffalo Pipeline Products & Ongoing Clinical Trials Overview 52

5.25 University College London Company Overview 55

5.25.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 55

5.26 University of Calgary Company Overview 56

5.26.1 University of Calgary Pipeline Products & Ongoing Clinical Trials Overview 56

5.27 University of Canterbury Company Overview 57

5.27.1 University of Canterbury Pipeline Products & Ongoing Clinical Trials Overview 57

5.28 University of Chicago Company Overview 58

5.28.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 58

5.29 University of Michigan Company Overview 59

5.29.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 59

5.30 University of South Florida Company Overview 60

5.30.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 60

5.31 Weinberg Medical Physics LLC Company Overview 61

5.31.1 Weinberg Medical Physics LLC Pipeline Products & Ongoing Clinical Trials Overview 61

5.32 XLV Diagnostics, Inc. Company Overview 62

5.32.1 XLV Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62

6 Mammography Equipment- Recent Developments 63

6.1 Oct 02, 2023: Oxford Instruments Welcomes New Chief Executive, Richard Tyson 63

6.2 Sep 18, 2023: Hitachi Vantara Appoints New GM for Sub-Saharan Africa 63

6.3 Sep 13, 2023: Davita Launches Community Health Tour to Provide Free Kidney Screenings and Education Coast-To-Coast 63

6.4 Sep 12, 2023: Hitachi Makes Executive Responsibility Change 64

6.5 Sep 07, 2023: Philips Reaches Resolution of US Economic Loss Litigation 64

6.6 Sep 05, 2023: Siemens Healthineers Expands Production Site in Rudolstadt, Germany and Creates New Jobs 64

6.7 Aug 28, 2023: ContextVision Appoints Richard Hallstrom as Chief Financial Officer 65

6.8 Aug 24, 2023: ContextVision Announces Strong Second Quarter With Solid Margin Growth 65

6.9 Aug 23, 2023: Sectra Announces Invitation to Presentation for Three-Month Interim Report 2023/2024 66

6.10 Aug 07, 2023: Notice of Annual General Meeting in Sectra AB (publ) 67

6.11 Jul 28, 2023: CoxHealth and Philips partner on virtual care solution 68

6.12 Jul 12, 2023: Revvity to Hold Earnings Call on Tuesday, August 1, 2023 69

6.13 Jun 13, 2023: Oxford Instruments Announcement of unaudited full-year results for the 12 months to 31 March 2023 69

6.14 Jun 13, 2023: Oxford Instruments Announces Preliminary Results for the 12 Months to 31 March 2023 70

6.15 Jun 02, 2023: Sectra’s year-end report 2022/2023: historic quarter to end another successful fiscal year-higher dividend proposed 71

6.16 May 15, 2023: iCAD reports financial results for first quarter ended March 31, 2023 72

6.17 May 15, 2023: Sectra invitation to presentation of year-end report 2022/2023 74

6.18 May 15, 2023: Konica Minolta announces summary of consolidated financial results for the fiscal year ended March 31, 2023 74

6.19 May 12, 2023: EIZO announces consolidated financial results for the fiscal year ended March 31, 2023 74

6.20 May 09, 2023: GE HealthCare Names James Saccaro Vice President and Chief Financial Officer 74

6.21 Apr 28, 2023: Siemens to announce second quarter results FY 2023 75

6.22 Apr 27, 2023: Hitachi reports financial results for year ended March 31, 2023 75

6.23 Apr 20, 2023: DMS Group announces record quarterly revenue: €10.1 million in the 1st quarter of 2023, organic growth +16% 76

6.24 Apr 17, 2023: iCAD Strengthens Leadership Team with Appointment of Chief Financial Officer and New Senior Executives 76

6.25 Apr 13, 2023: Ian Barkshire to retire and Richard Tyson to be appointed as Chief Executive Officer of Oxford Instruments 78

6.26 Apr 11, 2023: Volpara expands agreement with Banner Health to a five-year, full system contract 79

6.27 Mar 27, 2023: iCad lays off 28% of its workforce in restructuring plan 79

6.28 Mar 13, 2023: Hitachi Announces Executive Responsibility Changes 79

6.29 Mar 13, 2023: iCAD Announces Leadership Transition 80

6.30 Mar 13, 2023: iCAD Previews Fourth Quarter Financial Results, Full Report on March 28, 2023 80

6.31 Mar 10, 2023: Sectra Announces nine-month interim report 2022/2023 81

6.32 Mar 09, 2023: PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum 82

6.33 Mar 08, 2023: New Research at ECR 2023 Uses Volpara AI to Personalize, Optimize Breast Cancer Detection 82

6.34 Feb 21, 2023: Sectra Announces Invitation for presentation of nine-month interim report 2022/2023 83

6.35 Feb 14, 2023: Siemens Limited announces Q1 FY 2023 results; 80% increase in PAT from continuing operations 84

6.36 Feb 08, 2023: Siemens Announces Earnings Release and Financial Results for the First Quarter of Fiscal Year 2023 84

6.37 Feb 08, 2023: Siemens Announces Earnings Release Q1 FY 2023 85

6.38 Feb 02, 2023: Konica Minolta Announces Summary of Consolidated Financial Results for the Nine Months Ended December 31, 2022 87

6.39 Feb 01, 2023: Hitachi Announces Executive Changes 89

6.40 Feb 01, 2023: Hitachi Annnounces Consolidated Financial Results for the Third Quarter Ended December 31, 2022 90

6.41 Feb 01, 2023: Canon posts record revenues in medical business unit 90

6.42 Jan 31, 2023: EIZO Corp Announces Consolidated Financial Results for the Nine Months Ended December 31, 2022 (Under Japanese GAAP) 90

6.43 Jan 30, 2023: Philips to lay off 6,000 employees in drive to improve profitability 90

6.44 Jan 30, 2023: GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results 90

6.45 Jan 19, 2023: EIZO establishes new sales subsidiary in India with operations set to commence in April 2023 93

6.46 Jan 17, 2023: GE HealthCare to Announce Fourth Quarter and Full Year 2022 Results on January 30, 2023 94

6.47 Jan 10, 2023: GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook 94

6.48 Jan 08, 2023: Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2023 95

6.49 Jan 05, 2023: GE HealthCare appoints former Amazon exec as first chief technology officer 96

6.50 Dec 20, 2022: Sectra’s Nomination Committee for the 2023 Annual General Meeting 96

6.51 Dec 16, 2022: Sectra’s six-month interim report 2022/2023 97

6.52 Dec 07, 2022: Hitachi to hire 30,000 tech workers, defying global wave of layoffs 98

6.53 Dec 01, 2022: Invitation to presentation of Sectra’s six-month interim report 2022/2023 and date for CMD 2023 98

6.54 Dec 01, 2022: Hitachi Announces Quarterly Report (Second Quarter) 99

6.55 Nov 30, 2022: Mark Burgess Named President North America, Agfa HealthCare 99

6.56 Nov 27, 2022: Personalized breast care advancements from Volpara Health empower providers, patients, and partners at RSNA 2022 100

6.57 Nov 17, 2022: Siemens reports outstanding performance in fiscal 2022 101

6.58 Nov 16, 2022: Supervisory Board renews the term of office of Judith Wiese, Managing Board Member and Chief People & Sustainability Officer 103

6.59 Nov 10, 2022: iCAD Reports Financial Results for Third Quarter Ended September 30, 2022 103

6.60 Nov 08, 2022: PerkinElmer Announces Financial Results for the Third Quarter of 2022 106

6.61 Nov 08, 2022: Oxford Instruments Announcement of half-year results for the six months to 30 September 2022 107

6.62 Oct 31, 2022: Siemens appoints Hakan Ozdemir as CEO in Qatar 107

6.63 Oct 30, 2022: Siemens appoints Jamie Hoyzer as CEO in Oman 107

6.64 Oct 28, 2022: Hitachi reports financial results for Q2 ended September 30, 2022 108

6.65 Oct 27, 2022: iCAD to Report Third Quarter 2022 Financial Results on November 10, 2022 108

6.66 Oct 25, 2022: PDC Launches Comfort Cushion Mammography Pad to Help Breast Health Centers Improve the Patient Experience 108

6.67 Oct 24, 2022: Philips To Cut 4000 Jobs As Company Faces Multiple Challenges 108

6.68 Oct 18, 2022: Shimadzu Announces 1st Half Results & Financial Position for the Fiscal Year Ending March 2022 109

7 Appendix 110

7.1 Methodology 110

7.2 About GlobalData 113

7.3 Contact Us 113

7.4 Disclaimer 113

Table

Mammography Equipment – Pipeline Products by Stage of Development 11

Mammography Equipment – Pipeline Products by Segment 12

Mammography Equipment – Pipeline Products by Territory 13

Mammography Equipment – Pipeline Products by Regulatory Path 14

Mammography Equipment – Pipeline Products by Estimated Approval Date 15

Mammography Equipment – Ongoing Clinical Trials 16

Mammography Equipment Companies – Pipeline Products by Stage of Development 17

Mammography Equipment – Pipeline Products by Stage of Development 19

Agfa HealthCare NV Pipeline Products & Ongoing Clinical Trials Overview 21

DR18M Mammography Detector – Product Status 21

DR18M Mammography Detector – Product Description 21

Annalise-AI Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 22

Annalise Mammo – Product Status 22

Annalise Mammo – Product Description 22

Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview 23

Photoacoustic Mammography Device – Product Status 23

Photoacoustic Mammography Device – Product Description 23

CapeRay Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 24

Aceso – Product Status 24

Aceso – Product Description 24

Aegle – Product Status 25

Aegle – Product Description 25

PantoScanner Soteria – Product Status 25

PantoScanner Soteria – Product Description 26

Cooper Union for the Advancement of Science and Art Pipeline Products & Ongoing Clinical Trials Overview 27

At-Home Breast Cancer Screening System – Product Status 27

At-Home Breast Cancer Screening System – Product Description 27

Fischer Imaging Corp Pipeline Products & Ongoing Clinical Trials Overview 28

MammoCAT 2D System – Product Status 28

MammoCAT 2D System – Product Description 28

MammoCAT CT – Product Status 29

MammoCAT CT – Product Description 29

MammoCAT DBT – Product Status 29

MammoCAT DBT – Product Description 30

MammoCAT DM – Product Status 30

MammoCAT DM – Product Description 30

Florida International University Pipeline Products & Ongoing Clinical Trials Overview 31

Handheld Imager – Product Status 31

Handheld Imager – Product Description 31

FMI Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 32

ScintiStar Mammo LPX PET/CT – Product Status 32

ScintiStar Mammo LPX PET/CT – Product Description 32

GE Global Research Pipeline Products & Ongoing Clinical Trials Overview 33

PET-Mammogram-Biopsy System – Product Status 33

PET-Mammogram-Biopsy System – Product Description 33

GE HealthCare Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 34

Second Generation Tomosynthesis Unit – Product Status 34

Second Generation Tomosynthesis Unit – Product Description 34

Health Discovery Corp Pipeline Products & Ongoing Clinical Trials Overview 35

MammoSIGHT – Product Status 35

MammoSIGHT – Product Description 35

Imagine Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 36

STARLIGHT – Product Status 36

STARLIGHT – Product Description 36

Imaging Diagnostic Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37

CTLM 3.0 Scanner – Product Status 37

CTLM 3.0 Scanner – Product Description 37

CTLM System – Product Status 38

CTLM System – Product Description 38

Lawrence Livermore National Laboratory Pipeline Products & Ongoing Clinical Trials Overview 39

Phase Sensitive X-Ray Imager – Product Status 39

Phase Sensitive X-Ray Imager – Product Description 39

Micrima Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40

Maria System – Next Version – Product Status 40

Maria System – Next Version – Product Description 40

Microwave Vision SA Pipeline Products & Ongoing Clinical Trials Overview 41

Wavelia Microwave Breast Imaging System – Product Status 41

Wavelia Microwave Breast Imaging System – Product Description 41

Microwave Vision SA – Ongoing Clinical Trials Overview 42

Wavelia Microwave Breast Imaging System – Open-label,Single Site,Pilot Clinical Investigation to Assess Detectability and Sizing of Invasive Breast Cancers,Detectability of Benign Breast Lesions,Differentiation Between Malignant and Benign Breast Lesions Using Wavelia # 2 43

Mobile Electronic Diagnostics (MobED) Pipeline Products & Ongoing Clinical Trials Overview 44

TUSI – Product Status 44

TUSI – Product Description 44

NovaScan Inc Pipeline Products & Ongoing Clinical Trials Overview 45

Electrical Mammogram – Product Status 45

Electrical Mammogram – Product Description 45

PETsys Electronics SA Pipeline Products & Ongoing Clinical Trials Overview 46

Clear-PEM Sonic – Product Status 46

Clear-PEM Sonic – Product Description 46

Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 47

MicroDose 3D S90 – Product Status 47

MicroDose 3D S90 – Product Description 47

Positron Mammography Imaging Device – Product Status 48

Positron Mammography Imaging Device – Product Description 48

Real Time Tomography LLC Pipeline Products & Ongoing Clinical Trials Overview 49

Carbon Nanotube-Based Stationary Digital Breast Tomosynthesis System – Product Status 49

Carbon Nanotube-Based Stationary Digital Breast Tomosynthesis System – Product Description 49

The University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 50

Portable Breast Scanner – Product Status 50

Portable Breast Scanner – Product Description 50

TomoWave Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 51

LOUISA-3D Breast Imaging System – Product Status 51

LOUISA-3D Breast Imaging System – Product Description 51

University at Buffalo Pipeline Products & Ongoing Clinical Trials Overview 52

Dual Scan Mammoscope – Product Status 52

Dual Scan Mammoscope – Product Description 52

University at Buffalo – Ongoing Clinical Trials Overview 53

Dual Scan Mammoscope – A Study to Investigate the Photoacoustic and Utrasonic Characteristics of Breast Cancer and Ultimately Improve the Images Produced by the Dual Scan Mammoscope (DSM) 54

University College London Pipeline Products & Ongoing Clinical Trials Overview 55

X-Ray System – Breast Cancer – Product Status 55

X-Ray System – Breast Cancer – Product Description 55

University of Calgary Pipeline Products & Ongoing Clinical Trials Overview 56

TSAR System – Product Status 56

TSAR System – Product Description 56

University of Canterbury Pipeline Products & Ongoing Clinical Trials Overview 57

3D Digital Imaging System – Product Status 57

3D Digital Imaging System – Product Description 57

University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 58

Digital Specimen Tomosynthesis Imaging System – Product Status 58

Digital Specimen Tomosynthesis Imaging System – Product Description 58

University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 59

Computerized Detection System – Breast Cancer – Product Status 59

Computerized Detection System – Breast Cancer – Product Description 59

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 60

Computer-based System – Mammographic Calcifications Clusters – Product Status 60

Computer-based System – Mammographic Calcifications Clusters – Product Description 60

Weinberg Medical Physics LLC Pipeline Products & Ongoing Clinical Trials Overview 61

MRI-Compatible PEM Scanner – Product Status 61

MRI-Compatible PEM Scanner – Product Description 61

XLV Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62

Digital Mammography Machine 1824 – Product Status 62

Digital Mammography Machine 1824 – Product Description 62

Glossary 112

Figures

Mammography Equipment – Pipeline Products by Stage of Development 11

Mammography Equipment – Pipeline Products by Segment 12

Mammography Equipment – Pipeline Products by Territory 13

Mammography Equipment – Pipeline Products by Regulatory Path 14

Mammography Equipment – Pipeline Products by Estimated Approval Date 15

Mammography Equipment – Ongoing Clinical Trials 16

Frequently asked questions

Mammography Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Mammography Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Mammography Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Mammography Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.